A real report can still belong to a different batch. Here’s how to follow the evidence from laboratory paper to the product in your hand.
A COA records what happened to one submitted sample under specific test conditions. It does not automatically describe the seller’s whole inventory—or even the vial sitting in front of you.
Verification confirms the paper. Traceability connects that paper to inventory and then to your vial.
Verify the results directly with the issuing laboratory, through its report portal or the QR code on the report. Every Morris Peppy report opens on our Lab Results page, and we add the laboratory’s own verification link as soon as the lab publishes it.
Look for a lot number, batch size, test date, sample count, and selection method.
Match the lot, label, stated quantity, and documented packaging details.
A portal can prove that the lab issued a document. It cannot prove your vial came from the submitted sample’s batch.
Compare the report number, sample description, date, and results with the laboratory’s own record, reached through the lab’s portal or the report’s QR code—not merely the seller’s image.
The most useful image clearly shows the submitted vial’s label, lot number, cap, and stated quantity. Missing photos are common; their absence is not evidence of fraud.
Batch size and current inventory turn an indefinite claim into a specific question: “Is the product shipping today still from this tested lot?”
Typed text costs nothing to copy onto a listing—or an unrelated vial. A photograph showing that lot number on a whole physical vial is harder to fake casually because the labeled object had to exist when the image was taken.
A missing photo is common and neutral. A strong photo is an asymmetric positive signal: an honest seller loses nothing by providing it, while a seller reusing or relabeling stock has a reason to avoid the trail.
It still is not proof. A seller could stage one “hero vial” and ship something else. The photo simply raises the cost of the lie.
Read it from the vial itself, rather than trusting a caption beside the photo.
Some manufacturers assign cap colors by production run or date. When that convention is documented, the unobscured color provides a second batch detail; it is not meaningful by itself.
Two unrelated images still leave the reader trusting that they came from the same submission.
A natural, uncropped view is stronger than a screenshot of a screenshot or a tight crop showing only convenient text.
A promotional image reused for months does not connect today’s inventory to the tested batch.
A report has finite scope: it covers the specific batch that was tested. When those vials sell, the COA is spent. Nothing automatically stops the same verified document from remaining online while different, untested stock ships under it.
No document fully prevents reuse. The practical goal is to make the claim specific, costly to fake, and easier to challenge.
“This batch contained 500 vials” turns a vague trust question into a falsifiable one: “This report tested a 500-vial batch on this date—is today’s vial still from it?” Our Lab Results show each batch’s size and remaining vials.
A recent vial photo connects current inventory to the claim. One image recycled across months of listings is functionally no defense against COA reuse.
No individual buyer can verify sales volume. Across buyer reports, however, a “500-vial batch” apparently selling at volume eight months later becomes a pattern worth questioning.
| Sample | GLP-2 (TZ) · 30 mg |
| Lot / batch | MP-T30-BK-A04 · 210 vials |
| Laboratory ID | V260914-37 004 |
| Sample selection | 5 vials from the batch |
| Reported purity | >99.80% |
Purity is not identity, and neither confirms the advertised milligram amount.
“Pass,” a measured value, and a reporting ceiling communicate different things.
Ask what method was used, how many vials were tested, and how they were selected.
Each test answers a different question. None carries the whole quality claim by itself.
How much of the detected chromatographic signal is assigned to the target peak?
Is the sample’s measured mass consistent with the peptide named on the report?
Which elements were measured, in what units, and against which limits?
USP <61> microbial limits are the floor. Sterility is a stricter test that few sellers run.
Evidence improves from Pass/Fail only, to a numeric result, to a result with spike recovery and CV data that help expose assay interference.
Informal supply chains justify going beyond typical vendor frameworks. Ask what was screened—including fentanyl—by which method, and at what cutoff.
GLP-2 (TZ) 30 mg, lot MP-T30-BK-A04. Vanguard Laboratory report V260914-37 004, released September 30, 2026: purity >99.80%, 27.75 mg measured, all eight checks passed.
Five of five. And when a check is still open, we show that too: a report you can check beats a perfect-looking one you can’t.
See how we test Philippine research peptides, and the lots we rejected on Lab Results. Read why we threw away 710 vials.